What is Vertex Pharmaceuticals's stock repurchased during period, value?

Vertex Pharmaceuticals (VRTX) reported stock repurchased during period, value of $1.09B in Q3 2025.

How has Vertex Pharmaceuticals's stock repurchased during period, value changed year-over-year?

Vertex Pharmaceuticals's stock repurchased during period, value increased by 255.2% year-over-year, from $307.60M to $1.09B.

What does stock repurchased during period, value mean?

Total cash spent on buying back company shares.

Other

Stock Repurchased During Period, Value

Vertex Pharmaceuticals Stock Repurchased During Period, Value increased by 175.0% to $1.09B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 255.2%, from $307.60M to $1.09B.

Analysis

StatementIncome Statement

SectionOther

CategoryCapital Allocation

SignalContext dependent

VolatilityModerate

First reportedQ2 2013

Last reportedQ4 2025

How to read this metric

High repurchase activity often signals that management believes the stock is undervalued or that they have excess cash.

Detailed definition

The total cash value spent by the company to repurchase its own shares from the open market. This is a key mechanism for...

Peer comparison

Commonly compared across peers to evaluate capital return strategies.

Metric ID: is_wmt_stock_repurchased_value

Historical Data

8 periods

	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q2 '24	Q3 '24	Q2 '25	Q3 '25
Value	$106.90M	$106.90M	$106.90M	$106.90M	$315.80M	$307.60M	$397.30M	$1.09B
QoQ Change	—	+0.0%	+0.0%	+0.0%	+195.4%	-2.6%	+29.2%	+175.0%
YoY Change	—	—	—	—	+195.4%	+187.7%	+25.8%	+255.2%

Range$106.90M – $1.09B

CAGR+277.4%

Avg YoY Growth+166.0%

Median YoY Growth+191.6%

Current Streak2 quarters growth